ANGO – angiodynamics, inc. (US:NASDAQ)

News

AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care
AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance
????????????????????????????2035????4?2330??????????? [CNET News]
Reasons to Add AngioDynamics Stock to Your Portfolio for Now [Yahoo! Finance]
AngioDynamics (NASDAQ:ANGO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com